September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...
September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...
September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by ...
September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ...
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...
August 31, 2022 — Medtronic plc, a global leader in healthcare technology, announced it has entered into a strategic ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than ...
August 31, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), fully automated and normalized body ...
August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...
August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of ...
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...